Loading...
Loading...
Loading...
Loading...
Atlas Antibodies

![Lane 1: Marker [kDa]<br/>Lane 2: Human spleen](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19446/15712/atl-amab90905_anti-cd40-mab-clone-cl1673-atl-amab90905-wenhanced-validation_26289__25243.1783621183.jpg?compression=lossy)

![Lane 1: Marker [kDa]<br/>Lane 2: Human spleen](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19446/15712/atl-amab90905_anti-cd40-mab-clone-cl1673-atl-amab90905-wenhanced-validation_26289__25243.1783621183.jpg?compression=lossy)
| Product Specifications | |
| Application | WB, IHC |
| Reactivity | Human |
| Clonality | Monoclonal IgG1 (Clone No.: CL1673) |
| Host | Mouse |
| Gene ID - Mouse | ENSMUSG00000017652 |
| Gene ID - Rat | ENSRNOG00000018488 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) | |
| Datasheet | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) | |
| Datasheet | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) |
| Citations for Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) – 1 Found |
| Sadeghlar, Farsaneh; Vogt, Annabelle; Mohr, Raphael U; Mahn, Robert; van Beekum, Katrin; Kornek, Miroslaw; Weismüller, Tobias J; Branchi, Vittorio; Matthaei, Hanno; Toma, Marieta; Schmidt-Wolf, I G H; Kalff, Jörg C; Strassburg, Christian P; González-Carmona, Maria A. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells. Cancer Immunology, Immunotherapy : Cii. 2021;70(5):1451-1464. PubMed |
No reviews have been added for this product.
Try browsing our complete catalog of products.
Atlas Antibodies

![Lane 1: Marker [kDa]<br/>Lane 2: Human spleen](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19446/15712/atl-amab90905_anti-cd40-mab-clone-cl1673-atl-amab90905-wenhanced-validation_26289__25243.1783621183.jpg?compression=lossy)

![Lane 1: Marker [kDa]<br/>Lane 2: Human spleen](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19446/15712/atl-amab90905_anti-cd40-mab-clone-cl1673-atl-amab90905-wenhanced-validation_26289__25243.1783621183.jpg?compression=lossy)
| Product Specifications | |
| Application | WB, IHC |
| Reactivity | Human |
| Clonality | Monoclonal IgG1 (Clone No.: CL1673) |
| Host | Mouse |
| Gene ID - Mouse | ENSMUSG00000017652 |
| Gene ID - Rat | ENSRNOG00000018488 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) | |
| Datasheet | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) | |
| Datasheet | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) |
| Citations for Anti CD40 mAb (Clone CL1673, ATL-AMAb90905 w/enhanced validation) – 1 Found |
| Sadeghlar, Farsaneh; Vogt, Annabelle; Mohr, Raphael U; Mahn, Robert; van Beekum, Katrin; Kornek, Miroslaw; Weismüller, Tobias J; Branchi, Vittorio; Matthaei, Hanno; Toma, Marieta; Schmidt-Wolf, I G H; Kalff, Jörg C; Strassburg, Christian P; González-Carmona, Maria A. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells. Cancer Immunology, Immunotherapy : Cii. 2021;70(5):1451-1464. PubMed |